A 3-page brief on the latest research supporting multimodal peptide protocols for women 45–65 on GLP-1 therapy.
What's inside:
The Mayo Clinic + Lancet study showing women 45+ lost 35% more weight on tirzepatide when paired with hormone therapy
Current research on muscle preservation during GLP-1 treatment — and the peptide co-therapies being studied to address it
The clinical perspective on BPC-157 for GI side effect management
A 5-source reference list with direct links for further reading
A clean, professional PDF designed to be shared, printed, or referenced in conversation with your provider or patients
Useful for women navigating GLP-1 therapy, and for the clinicians supporting them.
